Pietro Poggio

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia

M. Brancaccio, A. Morotti, G. Carrà, 2018, Molecular Cancer.

Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms

M. Brancaccio, A. Morotti, G. Carrà, 2022, Cancers.

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

L. Conti, Aurora Savino, L. Avalle, 2021, Oncoimmunology.

Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression

M. Brancaccio, L. Seclì, Matteo Sorge, 2021, Frontiers in Cell and Developmental Biology.

Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

V. Poli, E. Hirsch, L. Conti, 2021, Cancer Research.

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia

M. Brancaccio, A. Morotti, S. Rocca, 2018, Molecular Cancer.